Skip to main content

Advertisement

SpringerLink
Log in

Pharmacokinetics of meropenem in plasma and cerebrospinal fluid in patients with intraventricular hemorrhage after lateral ventricle drainage

  • Letter to the Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Berger-Estilita J, Passer M, Giles M, Wiegand J, Merz TM (2018) Modalities and accuracy of diagnosis of external ventricular drainage-related infections: a prospective multicentre observational cohort study. Acta Neurochir 160:2039–2047

    Article  CAS  PubMed  Google Scholar 

  2. Humphreys H, Jenks P, Wilson J, Weston V, Bayston R, Waterhouse C, Moore A, Healthcare Infection Society Working Party on Neurosurgical Infections (2017) Surveillance of infection associated with external ventricular drains: proposed methodology and results from a pilot study. J Hosp Infect 95:154–160

    Article  CAS  PubMed  Google Scholar 

  3. Kohli G, Singh R, Herschman Y, Mammis A (2018) Infection incidence associated with external ventriculostomy placement: a comparison of outcomes in the emergency department, intensive care unit, and operating room. World Neurosurg 110:e135–e140

    Article  PubMed  Google Scholar 

  4. Blassmann U, Roehr AC, Frey OR, Vetter-Kerkhoff C, Thon N, Hope W, Briegel J, Huge V (2016) Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study. Crit Care 20:343

    Article  PubMed Central  PubMed  Google Scholar 

  5. Chaudhuri A, Martinez-Martin P, Kennedy PG et al (2008) EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS task force on acute bacterial meningitis in older children and adults. Eur J Neurol 15:649–659

    Article  CAS  PubMed  Google Scholar 

  6. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ (2004) Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 39:1267–1284

    Article  PubMed  Google Scholar 

  7. Tattevin P, Pulcini C (2017) Central nervous system infections: work in progress. Clin Microbiol Infect 23:599–600

    Article  CAS  PubMed  Google Scholar 

  8. Tunkel AR, Hasbun R, Bhimraj A et al (2017) 2017 Infectious Diseases Society of America’s Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clin Infect Dis 64:34–65

    Article  CAS  Google Scholar 

  9. Morbitzer KA, Jordan JD, Sullivan KA, Durr EA, Olm-Shipman CM, Rhoney DH (2016) Vancomycin pharmacokinetic parameters in patients with hemorrhagic stroke. Neurocrit Care 25:250–257

    Article  CAS  PubMed  Google Scholar 

  10. Kong L, Tang Y, Zhang X, Lu G, Yu M, Shi Q, Wu X (2017) Pharmacokinetic/pharmacodynamic analysis of meropenem for the treatment of nosocomial pneumonia in intracerebral hemorrhage patients by Monte Carlo simulation. Ann Pharmacother 51:970–975

    Article  CAS  PubMed  Google Scholar 

  11. Blassmann U, Roehr AC, Frey OR, Vetter-Kerkhoff C, Thon N, Hope W, Briegel J, Huge V (2016) Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study. Crit Care 20:343–352

    Article  PubMed Central  PubMed  Google Scholar 

  12. Zhang Y, Zhang J, Chen Y, Yu J, Cao G, Wu X, Chen M, Wu J, Zhao X (2017) Evaluation of meropenem penetration into cerebrospinal fluid in patients with meningitis after neurosurgery. World Neurosurg 98:525–531

    Article  PubMed  Google Scholar 

Download references

Funding

This study was supported by the Research Innovation Program for College Graduates of Bengbu Medical College (Byycx1761 and Byycxz1833).

Author information

Author notes

  1. Hongzhou Xu and Lingti Kong contributed equally to this work.

Authors and Affiliations

  1. Department of Emergency Internal Medicine, The First Affiliated Hospital of Bengbu Medical College, Bengbu, 233004, China

    Hongzhou Xu, Bo Xu & Xiaofei Wu

  2. Department of Pharmacy, The First Affiliated Hospital of Bengbu Medical College, Bengbu, 233004, China

    Lingti Kong

  3. Department of Endocrinology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, 233004, China

    Chenchen Wu

Authors
  1. Hongzhou Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lingti Kong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chenchen Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bo Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiaofei Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiaofei Wu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, H., Kong, L., Wu, C. et al. Pharmacokinetics of meropenem in plasma and cerebrospinal fluid in patients with intraventricular hemorrhage after lateral ventricle drainage. Eur J Clin Pharmacol 75, 595–597 (2019). https://doi.org/10.1007/s00228-018-02606-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-018-02606-9

Search

Navigation